Blog:
IsoPlexis Data Network
Industry pioneers' backed data straight to your inbox.
Checkpoint Therapy Development and Biomarkers: Why Single-Cell Proteomics Is a Powerful Source of Insight
Next Generation Quality and Potency Metric for Allogeneic CAR-T Cell Products
Next Generation Preclinical Advancement of CAR-T Therapy: Improved Function and Efficacy in Multiple Myeloma
CAR-T Leader Makes Strides in the Bispecifics Space: See What’s Next for Functional Single-Cell Proteomics
Value of Cellular Proteomics: Confirming Critical Cellular Immune Function After Making Complex Gene Edits in Solid Tumor Therapies
Value of Cellular Proteomics: Completing the Functional Puzzle
Why Difficult Combination Checkpoint Pre-Clinical Development Choice is Evolving with IsoPlexis’ Single-Cell Cytokine Analysis
Getting the Most Out of Your CAR-T Bioprocessing with the CliniMACS Prodigy® & IsoCode Single-Cell Chip
IsoPlexis, Kite Pharma, Takeda, and Legend Biotech Presented Panel at 2019 CAR-TCR Summit
Checkpoint Immunotherapy in Solid Tumor Is Evolving: Advancing Cellular Fitness & Precision Medicine with IsoPlexis’ Platform
Single-Cell Functional Proteomics is Leading the Wave in CAR-T Therapies
Single-Cell Biomarker Symposiums: Cutting Edge Single-Cell Proteomics Insights in Immunotherapy
Data Generated on IsoPlexis Platform Discussed and Presented at AACR Conference
FOCiS 2018 Day 2: Cancer Vaccine Correlates Revealed through Single-Cell Function
Joint Publication with Kite Pharma and NCI in Blood Journal: Preinfusion Polyfunctional Anti-CD19 Chimeric Antigen Receptor T Cells Associate with Clinical Outcomes in NHL
AACR 2018 Day 3: Increased polyfunctionality observed in samples treated with ACT+NKTR-214 vs ACT+IL-2
IsoPlexis’ New IsoLight Instrument Receives the Red Dot Design Award for Highest Design Quality
TRCCC 2018: Single-Cell TILs Polyfunctionality Associates with Clinical Outcome of Anti-PD-1 Therapy
ASCO-SITC 2018 Day 1: Increase in Polyfunctionality Observed Post Intratumoral Injection of TLR4 Agonist G100
IsoPlexis Wins 2017 Fierce Technology Innovation Award
ASH 2017 Day 1: Synergistic impact of antigen and rimiducid-dependent stimulatory signals on promoting polyfunctional GoCAR-T cells targeting prostate stem cell antigen (PSCA)
The Scientist Names IsoPlexis Technology The Top Innovation of 2017
Journal for ImmunoTherapy of Cancer Highlights New Single Cell Bioinformatics Tools From IsoPlexis Used To Characterize Differences in CAR-T Products
Categories
News
(10)
Single Cell Functional Biology
(10)
CAR T Therapy
(4)
Checkpoint & Combination Therapy
(3)
Events
(3)
Announcement
(1)
See all
Resources
Publications & Presentations
Press Releases
IsoPlexis News
Further Learning
Literature
Product & Workflow Support
Webinars
Videos
IsoPlexis U
